Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study.
Brendan J
BJ
Burchell
D000085:Acetates / Q000009:adverse effects* / Q000627:therapeutic use; D000588:Amines; D018592:Cross-Over Studies; D003509:Cyclohexanecarboxylic Acids; D004244:Dizziness / Q000139:chemically induced*; D004311:Double-Blind Method; D000077206:Gabapentin; D006261:Headache / Q000139:chemically induced*; D006801:Humans; D012107:Research Design; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D018401:Sample Size; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin